Dominic Piscitelli, the Chief Financial Officer of $ORIC, sold 300 shares of the company on 06-09-2025 for an estimated $3,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares of this class of stock. Following this trade, they now own 103,864 shares of this class of $ORIC stock.
$ORIC Insider Trading Activity
$ORIC insiders have traded $ORIC stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ORIC stock by insiders over the last 6 months:
- JACOB CHACKO (PRESIDENT AND CEO) sold 24,660 shares for an estimated $204,214
- DOMINIC PISCITELLI (Chief Financial Officer) has made 0 purchases and 3 sales selling 11,751 shares for an estimated $102,319.
- PRATIK S MULTANI (Chief Medical Officer) sold 8,850 shares for an estimated $73,293
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ORIC Hedge Fund Activity
We have seen 79 institutional investors add shares of $ORIC stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 2,478,045 shares (-63.7%) from their portfolio in Q1 2025, for an estimated $13,827,491
- VIKING GLOBAL INVESTORS LP added 2,141,692 shares (+48.3%) to their portfolio in Q1 2025, for an estimated $11,950,641
- MPM BIOIMPACT LLC added 1,399,514 shares (+inf%) to their portfolio in Q1 2025, for an estimated $7,809,288
- AVIDITY PARTNERS MANAGEMENT LP removed 1,265,200 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $7,059,816
- VR ADVISER, LLC removed 1,212,000 shares (-27.6%) from their portfolio in Q1 2025, for an estimated $6,762,960
- SILVERARC CAPITAL MANAGEMENT, LLC added 881,940 shares (+74.8%) to their portfolio in Q1 2025, for an estimated $4,921,225
- VIVO CAPITAL, LLC added 802,632 shares (+62.8%) to their portfolio in Q1 2025, for an estimated $4,478,686
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ORIC Analyst Ratings
Wall Street analysts have issued reports on $ORIC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 05/06/2025
To track analyst ratings and price targets for $ORIC, check out Quiver Quantitative's $ORIC forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
